Skip to main navigation
Skip to search
Skip to main content
University of Birmingham Home
Help & FAQ
Home
Research output
Profiles
Research units
Projects
Activities
Datasets
Equipment
Prizes
Press/Media
Search by expertise, name or affiliation
Anti-angiogenic alternatives to VEGF blockade
Kabir A Khan, Roy Bicknell
Immunology and Immunotherapy
Cardiovascular Sciences
Research output
:
Contribution to journal
›
Article
›
peer-review
21
Citations (Scopus)
286
Downloads (Pure)
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Anti-angiogenic alternatives to VEGF blockade'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Vascular Endothelial Growth Factor
100%
Antiangiogenic
100%
Angiogenesis
66%
Angiogenic
66%
Antiangiogenic Agents
66%
Tumor
33%
Extracellular Matrix
33%
Metastasis
33%
Guard
33%
Tumor Formation
33%
Tumor Development
33%
Treatment Goals
33%
Membrane Receptors
33%
Tumor Angiogenesis
33%
Cancer Therapy
33%
Membrane Components
33%
Antiangiogenic Therapy
33%
Overall Outcome
33%
Current Needs
33%
Historical Examples
33%
Angiogenic Proteins
33%
Medicine and Dentistry
Vasculotropin
100%
Antiangiogenic
100%
Angiogenesis
66%
Angiogenesis Inhibitor
66%
Neoplasm
33%
Extracellular Matrix
33%
Metastatic Carcinoma
33%
Carcinogenesis
33%
Tumor Angiogenesis
33%
Cancer Therapy
33%
Membrane Component
33%
Antiangiogenic Therapy
33%
Membrane Receptor
33%
Angiogenic Protein
33%
Pharmacology, Toxicology and Pharmaceutical Science
Vasculotropin
100%
Antiangiogenic
100%
Neoplasm
66%
Angiogenesis Inhibitor
66%
Malignant Neoplasm
33%
Carcinogenesis
33%
Membrane Receptor
33%
Angiogenic Protein
33%
Immunology and Microbiology
Angiogenesis
100%
Vasculotropin
100%
Angiogenesis Inhibitor
66%
Extracellular Matrix
33%
Angiogenic Protein
33%